Outcomes of Total Pancreatectomy Versus Pancreaticoduodenectomy for Surgical Management of Pancreatic Ductal Adenocarcinoma
Journal of Surgical Oncology · 2026-06 · 133 (8) · 1059-1068
DOI: 10.1002/jso.70260 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Surgical Oncology, online erschienen am 08.04.2026. Verfasst von Ann Byerley und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, Louisiana State University (LSU) Health, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreaticoduodenectomy, Pancreatectomy, Pancreatic Neoplasms. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) have a poor prognosis. Surgical resection provides the highest chance of improved survival. This study investigates the role of total pancreatectomy (TP) in the surgical management of PDAC based on clinicopathologic characteristics and the effect these factors have on patients' outcomes.
Methods
Data from the National Cancer Database for patients undergoing TP or pancreaticoduodenectomy (PD) was analyzed. Statistical tests included Chi‐square test, logistic regression, least squared means, and Cox proportional hazard model to determine frequency and percentage, odds ratios, and hazard ratio, respectively.
Results
Of patients receiving PDAC resection, more TP patients were uninsured. Tumors in the pancreatic body or an overlapping locations increase the odds of receiving TP. Most statistically significant differences in clinicopathologic characteristics between the groups were not clinically meaningful. Despite a slight increase in short‐term mortality for stage 2 patients receiving a TP, there was no clinically meaningful difference in overall survival.
Conclusion
TP conferred a minimally worsened short‐term survival for stage 2 PDAC, but oncologic outcomes and OS were similar for TP and PD. Therefore, surgical approach should be guided by individual patient characteristics and comorbidities, as long‐term oncologic outcomes between the two procedures are comparable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, Louisiana State University (LSU) Health, New Orleans, Louisiana, USA.
- Department of Community Science and Health Policy, Louisiana State University (LSU) Health School of Medicine, New Orleans, Louisiana, USA.
- LSU-LCMC Cancer Center, New Orleans, Louisiana, USA.
- Department of Interdisciplinary Oncology, Louisiana State University (LSU) Health School of Medicine, New Orleans, Louisiana, USA.
ORCID-Profile: Ann Byerley, Kevin Sullivan, Aimee Galatas
Zitieren
APA
Byerley, A., Danos, D., Sullivan, K., Littlefield, E., Galatas, A., & Moaven, O. (2026). Outcomes of Total Pancreatectomy Versus Pancreaticoduodenectomy for Surgical Management of Pancreatic Ductal Adenocarcinoma. Journal of Surgical Oncology, 133(8), 1059-1068. https://doi.org/10.1002/jso.70260
Vancouver
Byerley A, Danos D, Sullivan K, Littlefield E, Galatas A, Moaven O. Outcomes of Total Pancreatectomy Versus Pancreaticoduodenectomy for Surgical Management of Pancreatic Ductal Adenocarcinoma. Journal of Surgical Oncology. 2026;133(8):1059-1068. doi:10.1002/jso.70260
BibTeX
@article{Byerley2026,
author = {Byerley, Ann and Danos, Denise and Sullivan, Kevin and Littlefield, Ethan and Galatas, Aimee and Moaven, Omeed},
title = {Outcomes of Total Pancreatectomy Versus Pancreaticoduodenectomy for Surgical Management of Pancreatic Ductal Adenocarcinoma},
journal = {Journal of Surgical Oncology},
year = {2026},
volume = {133},
number = {8},
pages = {1059--1068},
doi = {10.1002/jso.70260}
}
EUVIMED